Tata Chemicals Limited recorded a consolidated net loss of Rs 17 crore in the initial quarter of FY27, contrasting with a net profit of Rs 252 crore in the same period last year. The company’s revenue from operations for the quarter concluding on June 30, 2026, stood at Rs 4,255 crore, showing a 14.4% rise from Rs 3,719 crore in the previous year.
Tata Chemicals’ Managing Director and CEO, R. Mukundan, acknowledged the company’s robust performance in the face of a challenging external environment during the June quarter. He highlighted that the company’s performance was sustained by increased sales and production volumes, efficient operations, and disciplined cost management.
Despite a double-digit revenue growth, Tata Chemicals faced pressure on its operating performance. Earnings before interest, tax, depreciation, and amortization (EBITDA) dropped by 14.5% to Rs 555 crore from Rs 649 crore in the prior year. Consequently, the EBITDA margin saw a significant contraction to 13% from 17.5% in the corresponding quarter of the previous fiscal year.
The company’s bottom line was impacted by the decline in operating margins, leading to a quarterly loss despite higher sales. The results reflect that cost challenges and an unfavorable operating environment offset the advantages of increased revenue during the period under review.
Mukundan outlined the company’s strategy of shifting its portfolio towards non-cyclical businesses by allocating capital strategically to establish a growth platform with stable earnings.
